Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy

Kengo Furuichi,Miho Shimizu,Yukio Yuzawa,Akinori Hara,Tadashi Toyama,Hiroshi Kitamura,Yoshiki Suzuki,Hiroshi Sato,Noriko Uesugi,Yoshifumi Ubara,Junichi Hohino,Satoshi Hisano,Yoshihiko Ueda,Shinichi Nishi,Hitoshi Yokoyama,Tomoya Nishino,Kentaro Kohagura,Daisuke Ogawa,Koki Mise,Yugo Shibagaki,Hirofumi Makino,Seiichi Matsuo,Takashi Wada,Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development,

DOI: https://doi.org/10.1007/s10157-017-1485-7

IF: 2.6212

2017-10-27

Clinical and Experimental Nephrology

Abstract:BackgroundThe Japanese classification of diabetic nephropathy reflects the risks of mortality, cardiovascular events and kidney prognosis and is clinically useful. Furthermore, pathological findings of diabetic nephropathy are useful for predicting prognoses. In this study, we evaluated the characteristics of pathological findings in relation to the Japanese classification of diabetic nephropathy and their ability to predict prognosis.MethodsThe clinical data of 600 biopsy-confirmed diabetic nephropathy patients were collected retrospectively from 13 centers across Japan. Composite kidney events, kidney death, cardiovascular events, all-cause mortality, and decreasing rate of estimated GFR (eGFR) were evaluated based on the Japanese classification of diabetic nephropathy.ResultsThe median observation period was 70.4 (IQR 20.9–101.0) months. Each stage had specific characteristic pathological findings. Diffuse lesions, interstitial fibrosis and/or tubular atrophy (IFTA), interstitial cell infiltration, arteriolar hyalinosis, and intimal thickening were detected in more than half the cases, even in Stage 1. An analysis of the impacts on outcomes in all data showed that hazard ratios of diffuse lesions, widening of the subendothelial space, exudative lesions, mesangiolysis, IFTA, and interstitial cell infiltration were 2.7, 2.8, 2.7, 2.6, 3.5, and 3.7, respectively. Median declining speed of eGFR in all cases was 5.61 mL/min/1.73 m2/year, and the median rate of declining kidney function within 2 years after kidney biopsy was 24.0%.ConclusionsThis study indicated that pathological findings could categorize the high-risk group as well as the Japanese classification of diabetic nephropathy. Further study using biopsy specimens is required to clarify the pathogenesis of diabetic kidney disease.

urology & nephrology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the relationship between the pathological features of diabetic nephropathy (DN) and the Japanese diabetic nephropathy classification, as well as its predictive ability for prognosis. Specifically, the research aims to:

1. **Evaluate pathological features**: By retrospectively collecting the clinical data of 600 biopsy - confirmed diabetic nephropathy patients from 13 centers in Japan, evaluate the pathological features of these patients at different stages.
2. **Predict prognosis**: Analyze the impact of these pathological features on composite renal events (dialysis, doubling of serum creatinine or halving of eGFR), renal death, cardiovascular events and all - cause mortality.
3. **Verify the classification system**: Confirm the validity of the Japanese diabetic nephropathy classification system, especially its application value in predicting high - risk patients.

### Research background
The Japanese diabetic nephropathy classification system is based on albuminuria levels and estimated glomerular filtration rate (eGFR), reflecting the risk of death, cardiovascular events and renal prognosis in patients with diabetic nephropathy. Pathological findings are also important for predicting the prognosis of diabetic nephropathy. However, there are currently few studies on the relationship between pathological features and clinical staging, and most of the study subjects have different levels of proteinuria and renal function.

### Methods
- **Data collection**: Clinical data of 600 diabetic nephropathy patients diagnosed by renal biopsy were collected from 13 centers in Japan.
- **Pathological examination**: Stained biopsy samples were examined by light microscopy, and nine glomerular lesions, two interstitial lesions and two vascular lesions were defined.
- **Statistical analysis**: Mann - Whitney U test, chi - square test, Kaplan - Meier survival curve and log - rank test were used for statistical analysis.

### Results
- **Baseline characteristics**: The study included 600 patients, with a median follow - up time of 70.4 months. The specific pathological features of patients at each stage were significantly different, and the pathological score increased with the increase of the stage.
- **Pathological features**: Even in stage 1 (normal albuminuria and preserved eGFR), 78.0% of cases had diffuse lesions, and more than half of the cases had interstitial fibrosis / tubular atrophy, interstitial cell infiltration, arteriolar hyalinosis and intimal thickening.
- **Impact on prognosis**: All 13 pathological features could significantly predict the occurrence of composite renal events. After adjusting for age and gender, each pathological feature showed different hazard ratios (HR) at different stages. For example, nodular lesions and microaneurysms had higher HR in stages 1 and 2, while interstitial fibrosis / tubular atrophy and interstitial cell infiltration had higher HR in stage 3.
- **eGFR decline rate**: The median eGFR decline rate in all cases was 5.90 mL/min/1.73 m²/year, and the median rate of renal function decline within 2 years was 24.9%. Both the eGFR decline rate and the decline rate increased with the increase of the Japanese diabetic nephropathy classification stage.

### Conclusion
This study, through large - scale pathological and clinical data analysis, has confirmed that pathological features can effectively classify high - risk diabetic nephropathy patients and supplement the prognostic value of the Japanese diabetic nephropathy classification system. Further research needs to use more biopsy specimens to clarify the pathogenesis of diabetic nephropathy.